NRIP1/RIP140 siRNA-mediated attenuation counteracts mitochondrial dysfunction in Down syndrome

Area of Science:

• Genetics
• Cell Biology
• Biochemistry

Background:

• Mitochondrial dysfunction is a hallmark of Down syndrome (DS), impacting disease severity.
• Downregulation of PGC-1α (PPARGC1A), a key mitochondrial regulator, and nuclear-encoded mitochondrial genes (NEMGs) is implicated in DS mitochondrial issues.
• The Hsa21 gene NRIP1 (RIP140) is a candidate regulator of NEMGs, known to negatively control PGC-1α pathways.

Purpose of the Study:

• To investigate if NRIP1 overexpression in DS contributes to mitochondrial dysfunction by downregulating PGC-1α and NEMGs.
• To determine if reducing NRIP1 levels can restore mitochondrial function in DS cells.

Main Methods:

• Utilized siRNA to decrease NRIP1 expression in trisomic human fetal fibroblasts (DS model).
• Assessed levels of PGC-1α and NEMGs.
• Evaluated mitochondrial function through reactive oxygen species (ROS) levels, ATP production, and mitochondrial activity.

Main Results:

• Decreasing NRIP1 expression led to increased PGC-1α and NEMG levels.
• Mitochondrial function was restored, evidenced by reduced ROS, increased ATP production, and enhanced mitochondrial activity.
• These findings confirm NRIP1's contribution to mitochondrial dysfunction in DS.

Conclusions:

• The Hsa21 gene NRIP1 plays a role in the mitochondrial dysfunction observed in Down syndrome.
• The NRIP1-PGC-1α axis presents a potential therapeutic target for improving mitochondrial function in DS.